PMID: 7518847Aug 1, 1994Paper

Cutaneous vasculitis associated with granulocyte colony-stimulating factor

Journal of the American Academy of Dermatology
K K Jain

Abstract

Several cases of cutaneous vasculitis have been reported in patients treated with granulocyte colony-stimulating factor (G-CSF). The purpose of this study was to determine the prevalence of cutaneous vasculitis in patients receiving G-CSF therapy, causal relation to the drug, and possible pathomechanisms. Review of the literature, retrieval of cases from the safety database of the manufacturer of G-CSF, and global assessment of the causal relation of the drug to adverse drug reactions were done. Eighteen cases of cutaneous vasculitis were found, of which only three have been published. A skin biopsy was done in 12 and showed leukocytoclastic vasculitis. Although cutaneous vasculitis was rare in patients treated for neutropenia associated with malignant disease and chemotherapy, it occurred in 6% of the patients with chronic benign neutropenias. Cutaneous vasculitis usually followed the increase of absolute neutrophil count (ANC) and subsided after the decrease of ANC. There was no recurrence if ANC was kept below 800/mm3. The course of G-CSF was completed in most patients. Cutaneous vasculitis should be recognized as an adverse reaction to G-CSF with low morbidity. It can be managed by reduction of dose or discontinuation of G-...Continue Reading

Citations

Jan 19, 2002·Current Rheumatology Reports·Marta Lucia Cuellar
Dec 20, 1995·Toxicology·T Vial, J Descotes
Dec 20, 2002·Clinics in Dermatology·Andreas Katsambas, Panagiota Riga
Dec 11, 1999·Clinics in Dermatology·A Del RossoM Matucci-Cerinic
Jul 8, 2000·Pediatric Dermatology·A TorreloA Zambrano
Apr 17, 2002·Seminars in Hematology·Gordon Starkebaum
Sep 25, 2012·The American Journal of Dermatopathology·Mai P Hoang, Daniela Kroshinsky
Oct 7, 2005·Arthritis Research & Therapy·Franco CapsoniAlberto Zanella
Jan 25, 2011·Autoimmunity Reviews·Kam A Newman, Mojtaba Akhtari
Mar 24, 2007·Clinical Cornerstone·Lee S Schwartzberg
May 1, 1997·Baillière's Clinical Rheumatology·C MatY Tüzün
Oct 1, 1996·Journal of the American Academy of Dermatology·M A RichardD Maraninchi
Mar 1, 1996·Journal of the American Academy of Dermatology·L F GlassJ L Messina
Nov 14, 2001·Dermatologic Clinics·L E Gibson
May 1, 1997·Rheumatic Diseases Clinics of North America·C S George, A E Lichtin
Apr 21, 2004·Journal of the European Academy of Dermatology and Venereology : JEADV·S Alvarez-RuizA García-Díez
Jun 28, 2001·Leukemia & Lymphoma·S PaydaşB Sahin
Aug 8, 1998·Journal of Cutaneous Pathology·R ValksJ Fraga
Apr 7, 2005·Journal of Cutaneous Pathology·Ingrid H WolfH Kerl
Feb 18, 2006·Dermatology : International Journal for Clinical and Investigative Dermatology·Marta FerranRamon M Pujol
Jun 21, 2015·Clinical Journal of the American Society of Nephrology : CJASN·Jonathan J HoganJai Radhakrishnan
Jan 24, 2015·The Open Rheumatology Journal·Mohammad Bagher OwliaMojtaba Akhtari
Mar 19, 2003·Journal of Cutaneous Pathology·A Neil CrowsonCynthia M Magro
Aug 9, 2003·Expert Opinion on Drug Safety·Mittie K Doyle, Marta L Cuellar
Jan 31, 2002·The Annals of Pharmacotherapy·Sandra M ten HolderRonald J Falk
Nov 29, 2001·Rheumatic Diseases Clinics of North America·P A Merkel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.